Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.
作者信息
Glascock Jacqueline, Sampson Jacinda, Connolly Anne M, Darras Basil T, Day John W, Finkel Richard, Howell R Rodney, Klinger Katherine W, Kuntz Nancy, Prior Thomas, Shieh Perry B, Crawford Thomas O, Kerr Douglas, Jarecki Jill
机构信息
Cure SMA, Elk Grove Village, IL, USA.
Stanford University, Stanford, CA, USA.
出版信息
J Neuromuscul Dis. 2020;7(2):97-100. doi: 10.3233/JND-190468.
Abstract
摘要
相似文献
1
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.
J Neuromuscul Dis. 2020;7(2):97-100. doi: 10.3233/JND-190468.
2
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
J Neuromuscul Dis. 2018;5(2):145-158. doi: 10.3233/JND-180304.
3
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.
Nat Med. 2022 Jul;28(7):1381-1389. doi: 10.1038/s41591-022-01866-4. Epub 2022 Jun 17.
4
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.
Nat Med. 2022 Jul;28(7):1390-1397. doi: 10.1038/s41591-022-01867-3. Epub 2022 Jun 17.
5
Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
Vojnosanit Pregl. 2015 Oct;72(10):859-63. doi: 10.2298/vsp140328072z.
6
Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening.
Genes (Basel). 2024 Jun 29;15(7):858. doi: 10.3390/genes15070858.
7
Sleep disordered breathing in infants identified through newborn screening with spinal muscular atrophy.
Sleep Med. 2023 Nov;111:161-169. doi: 10.1016/j.sleep.2023.09.019. Epub 2023 Sep 25.
8
Spinal muscular atrophy: a time for screening.
Curr Opin Pediatr. 2010 Dec;22(6):696-702. doi: 10.1097/MOP.0b013e32833f3046.
9
Infantile spinal muscular atrophy (SMA).
Arch Pediatr. 2020 Dec;27(7S):7S1-7S2. doi: 10.1016/S0929-693X(20)30268-2.
10
[Nusinersen in the treatment of 4 children with presymptomatic spinal muscular atrophy].
Zhonghua Er Ke Za Zhi. 2024 Aug 2;62(8):786-788. doi: 10.3760/cma.j.cn112140-20240307-00159.
引用本文的文献
1
Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan.
Orphanet J Rare Dis. 2025 Apr 24;20(1):197. doi: 10.1186/s13023-025-03697-1.
2
What did we learn from new treatments in SMA? A narrative review.
Acta Myol. 2025 Mar;44(1):28-32. doi: 10.36185/2532-1900-1043.
3
Views of the Public and Healthcare Professionals on Newborn Screening for Spinal Muscular Atrophy and the Potential for Detecting Adult-Onset Types in Patients-in-Waiting in Hong Kong.
Cureus. 2025 Feb 17;17(2):e79190. doi: 10.7759/cureus.79190. eCollection 2025 Feb.
4
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience.
Muscle Nerve. 2025 Mar;71(3):414-421. doi: 10.1002/mus.28329. Epub 2025 Jan 2.
5
A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based study.
Lancet Reg Health West Pac. 2024 Nov 6;53:101237. doi: 10.1016/j.lanwpc.2024.101237. eCollection 2024 Dec.
6
Copy Number Association with Spinal Muscular Atrophy Severity: Insights from Colombian Patients.
J Clin Med. 2024 Oct 25;13(21):6402. doi: 10.3390/jcm13216402.
7
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.
Neurol Clin Pract. 2025 Feb;15(1):e200374. doi: 10.1212/CPJ.0000000000200374. Epub 2024 Oct 8.
8
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Arq Neuropsiquiatr. 2024 Oct;82(10):1-9. doi: 10.1055/s-0044-1791201. Epub 2024 Oct 13.
9
Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States.
Int J Neonatal Screen. 2024 Aug 16;10(3):58. doi: 10.3390/ijns10030058.
10
Our Journey from Individual Efforts to Nationwide Support: Implementing Newborn Screening for Spinal Muscular Atrophy in Serbia.
Int J Neonatal Screen. 2024 Aug 15;10(3):57. doi: 10.3390/ijns10030057.
本文引用的文献
1
Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function.
Neuromuscul Disord. 2018 Jul;28(7):582-585. doi: 10.1016/j.nmd.2018.05.010. Epub 2018 Jun 1.
2
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
J Neuromuscul Dis. 2018;5(2):145-158. doi: 10.3233/JND-180304.
Zotero 插件